Pericarditis
Pericarditis, Constrictive
Pericarditis, Tuberculous
Pericardiectomy
Pericardial Effusion
Cardiac Tamponade
Cardiomyopathy, Restrictive
Pericardium
Tuberculosis, Cardiovascular
Pleurodynia, Epidemic
Myocarditis
Carcinoid heart disease from ovarian primary presenting with acute pericarditis and biventricular failure. (1/361)
A case is described of a 54 year old woman who had acute pericarditis with large exudative effusion accompanied by severe right and left ventricular failure. The patient was finally diagnosed with carcinoid heart disease from an ovarian carcinoid teratoma. She was treated with octreotide--a somatostatin analogue--followed by radical surgical resection of the neoplasm. At one year follow up only mild carcinoid tricuspid regurgitation remained. Only 16 cases of carcinoid heart disease from an ovarian primary have been described in literature. Moreover clinically manifest acute, nonmetastatic pericarditis and left heart failure are not considered as possible presentations of carcinoid heart disease, whatever the origin. In a recent series a small pericardial effusion was considered an infrequent and unexpected echocardiographic finding in carcinoid heart patients. One case of "carcinoid pericarditis" has previously been described as a consequence of pericardial metastasis. Left sided heart involvement is usually caused by bronchial carcinoids or patency of foramen ovale; both were excluded in the case presented. (+info)Primary right atrial angiosarcoma mimicking acute pericarditis, pulmonary embolism, and tricuspid stenosis. (2/361)
A 29 year old white man presented to the emergency room with new onset pleuritic chest pain and shortness of breath. He was initially diagnosed as having viral pericarditis and was treated with non-steroidal anti-inflammatory drugs. A few weeks later he developed recurrent chest pain with cough and haemoptysis. Chest radiography, cardiac examination, transthoracic and transoesophageal echocardiography pointed to a mass that arose from the posterior wall of the right atrium, not attached to the interatrial septum, which protruded into the lumen of the right atrium causing intermittent obstruction of inflow across the tricuspid valve. Contrast computed tomography of the chest showed a right atrial mass extending to the anterior chest wall. The lung fields were studded with numerous pulmonary nodules suggestive of metastases. A fine needle aspiration of the pulmonary nodule revealed histopathology consistent with spindle cell sarcoma thought to originate in the right atrium. Immunohistochemical stains confirmed that this was an angiosarcoma. There was no evidence of extracardiac origin of the tumour. The patient was treated with chemotherapy and radiation. This case highlights the clinical presentation, rapid and aggressive course of cardiac angiosarcomas, and the diagnostic modalities available for accurate diagnosis. (+info)One-step reverse transcriptase PCR method for detection of Borrelia burgdorferi mRNA in mouse Lyme arthritis tissue samples. (3/361)
A one-step reverse transcriptase PCR (RT-PCR) method for detection of Borrelia burgdorferi mRNA in infected C3H mice is described. This simple procedure, less prone to nucleic acid cross-contamination than the standard method, was found to be 10-fold more sensitive than a classical two-step RT-PCR assay. By using one-step RT-PCR, flagellin mRNAs were detected in synovial and heart tissues from all seven infected mice tested. (+info)Intrapericardial streptokinase in purulent pericarditis. (4/361)
Six consecutive children with proven purulent pericarditis were treated with pericardial irrigation with streptokinase. Mean (SD) 861 (678) ml (range 240-2000) of thick purulent fluid was drained, and five children had complete clearance of the pus within 3-8 days. One child developed intrapericardial haemorrhage with a submitral pseudoaneurysm and underwent patch closure of the neck of the aneurysm as well as anterior pericardiectomy. Follow up of 13 to 30 months revealed no pericardial constriction. (+info)Restrictive pericarditis. (5/361)
BACKGROUND: Pericardial thickening is an uncommon complication of cardiac surgery. OBJECTIVES: To study pericardial thickening as the cause of severe postoperative venous congestion. SUBJECTS: Two men, one with severe aortic stenosis and single coronary artery disease, and one with coronary artery disease after an old inferior infarction. Both had coronary artery bypass grafting surgery. METHODS: Magnetic resonance imaging (MRI), Doppler echocardiography, and cardiac catheterisation. RESULTS: Venous pressure was raised in both patients. MRI showed mildly thickened pericardium, and cardiac catheterisation indicated diastolic equalization of pressures in the four chambers. Jugular venous pulse showed a dominant "Y" descent coinciding with early diastolic flow in the superior vena cava, and mitral and tricuspid Doppler forward flow proved restrictive physiology. The clinical background suggested pericardial disease so both patients had pericardiectomy. This proved the pericardium to be thickened; the extent of fibrosis also involved the epicardium. CONCLUSIONS: Although rare, restrictive pericarditis (restrictive ventricular physiology resulting from pericardial disease) should be considered to be a separate diagnostic entity because its pathological basis and treatment are different from intrinsic myocardial disease. This diagnosis may be confirmed by standard investigational techniques or may require diagnostic thoracotomy. (+info)Left ventricular pseudoaneurysm complicating infective pericarditis. (6/361)
Cross sectional echocardiography demonstrated a pseudoaneurysm of the left ventricular posterolateral wall close to the atrioventricular junction in a 4 year old girl with infective pericarditis complicating lobar pneumonia. Colour flow Doppler demonstrated bidirectional flow across the communication hole. Surgical resection was successful. (+info)Coxiella burnetii pericarditis: report of 15 cases and review. (7/361)
Q fever is characterized by its clinical polymorphism, and pericarditis associated with Q fever has occasionally been described. Herein we report 15 cases of Coxiella burnetii pericarditis, 9 from our data bank and 6 encountered within the past 12 months. Three patients presented with life-threatening tamponade. We compare our cases with the 18 previously reported and with 60 Q fever-matched controls at our center. This study showed that Q fever pericarditis can present as acute as well as chronic disease; we describe relapse after 6 months in association with a serological profile compatible with the chronic form of disease (phase I C. burnetii IgG titer of > or = 800). Discriminant factors among patients and controls are age of > 52 years (adjusted odds ratio [OR], 5.66), the occurrence of general symptoms such as arthralgias or myalgias (adjusted OR, 6.54), and a normal erythrocyte sedimentation rate (adjusted OR, 16.37). No specific symptoms or underlying cardiac predispositions are observed. (+info)New insights regarding the atrial flutter reentrant circuit : studies in the canine sterile pericarditis model. (8/361)
Background-We studied atrial activation during induced atrial flutter in the canine sterile pericarditis model to test the hypothesis that the atrial flutter reentrant circuit includes a septal component. Methods and Results-We studied 10 episodes of induced, sustained (>5 minutes) atrial flutter in 9 dogs. In all episodes, the reentrant circuit included a septal component. In 6 episodes, there were 2 reentrant circuits, one in the right atrial free wall and the second involving the atrial septum, Bachmann's bundle, and the right atrial free wall; both circuits shared a pathway in the right atrial free wall (figure-of-eight). The direction (superior or inferior) of the septal wave front of the second circuit correlated with the direction (clockwise or counterclockwise, respectively) of the right atrial free-wall circuit. A line of functional block in the right atrial free wall was part of both reentrant circuits. In the other 4 atrial flutter episodes, only 1 reentrant circuit was present, with activation in an inferior-to-superior direction in the septum and a superior-to-inferior direction in the right atrial free wall in 2 episodes and in the opposite direction in the other 2 episodes. In all atrial flutter episodes, the flutter wave polarity in ECG lead II was determined by the direction of activation in the left atrium; polarity was positive when the direction was superior to inferior and negative when the direction was inferior to superior. Conclusions-In this model of atrial flutter, the reentrant circuit (1) always included a septal component, (2) did not always require a right atrial free-wall reentrant circuit, (3) demonstrated figure-of-eight reentry when a reentrant circuit was present in the right atrial free wall, and (4) was associated with a line of functional block in the right atrial free wall. (+info)Pericarditis is a medical condition characterized by inflammation of the pericardium, which is the thin sac-like membrane that surrounds the heart and contains serous fluid to reduce friction during heartbeats. The inflammation can cause symptoms such as chest pain, shortness of breath, and sometimes fever.
The pericardium has two layers: the visceral pericardium, which is tightly adhered to the heart's surface, and the parietal pericardium, which lines the inner surface of the chest cavity. Normally, there is a small amount of fluid between these two layers, allowing for smooth movement of the heart within the chest cavity.
In pericarditis, the inflammation causes the pericardial layers to become irritated and swollen, leading to an accumulation of excess fluid in the pericardial space. This can result in a condition called pericardial effusion, which can further complicate the situation by putting pressure on the heart and impairing its function.
Pericarditis may be caused by various factors, including viral or bacterial infections, autoimmune disorders, heart attacks, trauma, or cancer. Treatment typically involves addressing the underlying cause, managing symptoms, and reducing inflammation with medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine, or corticosteroids. In severe cases, pericardiocentesis (removal of excess fluid from the pericardial space) or surgical intervention may be necessary.
Constrictive pericarditis is a medical condition characterized by the inflammation and thickening of the pericardium, which is the sac-like membrane that surrounds the heart. This inflammation leads to scarring and thickening of the pericardium, causing it to become stiff and inflexible. As a result, the heart's ability to fill with blood between beats is restricted, leading to symptoms such as shortness of breath, fatigue, and fluid retention.
In contrastive pericarditis, the thickened and scarred pericardium restricts the normal movement of the heart within the chest cavity, leading to a characteristic pattern of hemodynamic abnormalities. These include equalization of diastolic pressures in all cardiac chambers, increased systemic venous pressure, and decreased cardiac output.
The most common causes of constrictive pericarditis include prior infection, radiation therapy, autoimmune disorders, and previous heart surgery. Diagnosis typically involves a combination of medical history, physical examination, imaging studies such as echocardiography or MRI, and sometimes invasive testing such as cardiac catheterization. Treatment may involve medications to manage symptoms and reduce inflammation, as well as surgical removal of the pericardium (pericardiectomy) in severe cases.
Tuberculous pericarditis is a specific form of pericarditis (inflammation of the pericardium, the thin sac-like membrane that surrounds the heart) that is caused by the bacterial infection of Mycobacterium tuberculosis. This type of pericarditis is more common in areas where tuberculosis is prevalent and can lead to serious complications if not diagnosed and treated promptly.
In tuberculous pericarditis, the bacteria typically spread from the lungs (the most common site of TB infection) or other infected organs through the bloodstream to the pericardium. The infection causes an inflammatory response, leading to the accumulation of fluid in the pericardial space (pericardial effusion), which can put pressure on the heart and impair its function. In some cases, the inflammation may lead to the formation of scar tissue, causing the pericardium to thicken and constrict, a condition known as constrictive pericarditis.
Symptoms of tuberculous pericarditis can include chest pain, cough, fever, fatigue, weight loss, and difficulty breathing. Diagnosis typically involves a combination of medical history, physical examination, imaging tests (such as echocardiography, CT scan, or MRI), and laboratory tests (including analysis of the pericardial fluid). Treatment usually consists of a long course of antibiotics specific to TB, along with anti-inflammatory medications and close monitoring for potential complications.
Pericardiectomy is a surgical procedure that involves the removal of all or part of the pericardium, which is the sac-like membrane surrounding the heart. This surgery is typically performed to treat chronic or recurrent pericarditis, constrictive pericarditis, or pericardial effusions that do not respond to other treatments. Pericardiectomy can help reduce symptoms such as chest pain, shortness of breath, and fluid buildup around the heart, improving the patient's quality of life and overall prognosis.
Pericardial effusion is an abnormal accumulation of fluid in the pericardial space, which is the potential space between the two layers of the pericardium - the fibrous and serous layers. The pericardium is a sac that surrounds the heart to provide protection and lubrication for the heart's movement during each heartbeat. Normally, there is only a small amount of fluid (5-15 mL) in this space to ensure smooth motion of the heart. However, when an excessive amount of fluid accumulates, it can cause increased pressure on the heart, leading to various complications such as decreased cardiac output and even cardiac tamponade, a life-threatening condition that requires immediate medical attention.
Pericardial effusion may result from several causes, including infections (viral, bacterial, or fungal), inflammatory conditions (such as rheumatoid arthritis, lupus, or cancer), trauma, heart surgery, kidney failure, or iatrogenic causes. The symptoms of pericardial effusion can vary depending on the rate and amount of fluid accumulation. Slowly developing effusions may not cause any symptoms, while rapid accumulations can lead to chest pain, shortness of breath, cough, palpitations, or even hypotension (low blood pressure). Diagnosis is usually confirmed through imaging techniques such as echocardiography, CT scan, or MRI. Treatment depends on the underlying cause and severity of the effusion, ranging from close monitoring to drainage procedures or medications to address the root cause.
Cardiac tamponade is a serious medical condition that occurs when there is excessive fluid or blood accumulation in the pericardial sac, which surrounds the heart. This accumulation puts pressure on the heart, preventing it from filling properly and reducing its ability to pump blood effectively. As a result, cardiac output decreases, leading to symptoms such as low blood pressure, shortness of breath, chest pain, and a rapid pulse. If left untreated, cardiac tamponade can be life-threatening, requiring emergency medical intervention to drain the fluid and relieve the pressure on the heart.
Restrictive cardiomyopathy (RCM) is a type of heart muscle disorder characterized by impaired relaxation and filling of the lower chambers of the heart (the ventricles), leading to reduced pump function. This is caused by stiffening or rigidity of the heart muscle, often due to fibrosis or scarring. The stiffness prevents the ventricles from filling properly with blood during the diastolic phase, which can result in symptoms such as shortness of breath, fatigue, and fluid retention.
RCM is a less common form of cardiomyopathy compared to dilated or hypertrophic cardiomyopathies. It can be idiopathic (no known cause) or secondary to other conditions like amyloidosis, sarcoidosis, or storage diseases. Diagnosis typically involves a combination of medical history, physical examination, echocardiography, and sometimes cardiac MRI or biopsy. Treatment is focused on managing symptoms and addressing underlying causes when possible.
Pericardiocentesis is a medical procedure where a needle or a catheter is inserted into the pericardial sac, the thin fluid-filled space surrounding the heart, to remove excess fluids or air that has accumulated. This buildup can put pressure on the heart and impede its function, leading to various cardiac symptoms such as chest pain, shortness of breath, and palpitations. The procedure is often guided by echocardiography or fluoroscopy to ensure proper placement and minimize risks. Pericardiocentesis may be performed as an emergency treatment or a scheduled intervention, depending on the patient's condition.
The pericardium is the double-walled sac that surrounds the heart. It has an outer fibrous layer and an inner serous layer, which further divides into two parts: the parietal layer lining the fibrous pericardium and the visceral layer (epicardium) closely adhering to the heart surface.
The space between these two layers is filled with a small amount of lubricating serous fluid, allowing for smooth movement of the heart within the pericardial cavity. The pericardium provides protection, support, and helps maintain the heart's normal position within the chest while reducing friction during heart contractions.
"Cardiovascular Tuberculosis" refers to a form of tuberculosis (TB) where the bacteria (Mycobacterium tuberculosis) infects the heart or the blood vessels. This is a less common manifestation of TB, but it can have serious consequences if left untreated.
In cardiovascular TB, the bacteria can cause inflammation and damage to the heart muscle (myocarditis), the sac surrounding the heart (pericarditis), or the coronary arteries that supply blood to the heart muscle. This can lead to symptoms such as chest pain, shortness of breath, coughing, fatigue, and fever. In severe cases, it can cause heart failure or life-threatening arrhythmias.
Cardiovascular TB is usually treated with a combination of antibiotics that are effective against the TB bacteria. The treatment may last for several months to ensure that all the bacteria have been eliminated. In some cases, surgery may be necessary to repair or replace damaged heart valves or vessels. Early diagnosis and treatment can help prevent serious complications and improve outcomes in patients with cardiovascular TB.
Suppuration is the process of forming or discharging pus. It is a condition that results from infection, tissue death (necrosis), or injury, where white blood cells (leukocytes) accumulate to combat the infection and subsequently die, forming pus. The pus consists of dead leukocytes, dead tissue, debris, and microbes (bacteria, fungi, or protozoa). Suppuration can occur in various body parts such as the lungs (empyema), brain (abscess), or skin (carbuncle, furuncle). Treatment typically involves draining the pus and administering appropriate antibiotics to eliminate the infection.
Cardiovascular infections, also known as infective endocarditis, are infections that affect the inner layer of the heart, including the heart valves. These infections are usually caused by bacteria, but they can also be caused by fungi or other microorganisms. They can occur when bacteria or other germs enter the bloodstream and then settle in the heart.
There are several types of cardiovascular infections, including:
* Native Valve Endocarditis: This occurs when an infection affects the heart valves that are present at birth.
* Prosthetic Valve Endocarditis: This occurs when an infection affects an artificial heart valve.
* Intracardiac Device-Related Infections: These infections can occur in people who have devices such as pacemakers or implantable defibrillators.
* Infectious Myocarditis: This is an inflammation of the heart muscle caused by an infection.
Symptoms of cardiovascular infections may include fever, chills, fatigue, shortness of breath, chest pain, and a new or changing heart murmur. Treatment typically involves several weeks of antibiotics, and in some cases, surgery may be necessary to remove the infected tissue. Prevention measures include good oral hygiene, prompt treatment of skin infections, and prophylactic antibiotics for certain high-risk individuals undergoing dental or surgical procedures.
Epidemic pleurodynia, also known as Bornholm disease or devils' grip, is a self-limiting viral illness characterized by sudden onset of severe, stabbing chest or upper abdominal pain. It is caused most commonly by an enterovirus, often Coxsackie A or B.
The hallmark of epidemic pleurodynia is the pleuritic nature of the pain, which is aggravated by deep breathing, coughing, or movement. The muscle spasms can be so intense that they cause the patient to assume a fetal position in order to minimize the discomfort. Other symptoms may include fever, headache, nausea, vomiting, and generalized weakness.
The term "epidemic" refers to the fact that this disease tends to occur in outbreaks, particularly during the summer and fall months. However, sporadic cases can also occur throughout the year. The illness typically lasts for 5-10 days but may rarely persist for several weeks.
Treatment is generally supportive and includes rest, hydration, and analgesics for pain relief. Antiviral medications are not usually recommended, as they have not been shown to significantly affect the course of the illness.
Myocarditis is an inflammation of the myocardium, which is the middle layer of the heart wall. The myocardium is composed of cardiac muscle cells and is responsible for the heart's pumping function. Myocarditis can be caused by various infectious and non-infectious agents, including viruses, bacteria, fungi, parasites, autoimmune diseases, toxins, and drugs.
In myocarditis, the inflammation can damage the cardiac muscle cells, leading to decreased heart function, arrhythmias (irregular heart rhythms), and in severe cases, heart failure or even sudden death. Symptoms of myocarditis may include chest pain, shortness of breath, fatigue, palpitations, and swelling in the legs, ankles, or abdomen.
The diagnosis of myocarditis is often based on a combination of clinical presentation, laboratory tests, electrocardiogram (ECG), echocardiography, cardiac magnetic resonance imaging (MRI), and endomyocardial biopsy. Treatment depends on the underlying cause and severity of the disease and may include medications to support heart function, reduce inflammation, control arrhythmias, and prevent further damage to the heart muscle. In some cases, hospitalization and intensive care may be necessary.
Cardanolides are a type of steroid compound that are found in certain plants, particularly in the family Apocynaceae. These compounds have a characteristic structure that includes a five-membered lactone ring attached to a steroid nucleus, and they are known for their ability to inhibit the sodium-potassium pump (Na+/K+-ATPase) in animal cells. This property makes cardanolides toxic to many organisms, including humans, and they have been used as heart poisons and insecticides.
One of the most well-known cardanolides is ouabain, which is found in the seeds of several African plants and has been used traditionally as a medicine for various purposes, including as a heart stimulant and a poison for hunting. Other examples of cardanolides include digoxin and digitoxin, which are derived from the foxglove plant (Digitalis purpurea) and are used in modern medicine to treat heart failure and atrial arrhythmias.
It's worth noting that while cardanolides have important medical uses, they can also be highly toxic if ingested or otherwise introduced into the body in large amounts. Therefore, it's essential to use these compounds only under the supervision of a qualified healthcare professional.